In addition, the full extent to which the DNGR-1-sGSN cross-presentation axis shapes the antigenic repertoire of cancer cells will require analysis of immunoediting of chemically induced cancers (Matsushita et al., 2012) in the different mouse strains described in this report. The gene discussed is CLEC9A; the disease is cancer.